Assessment of outcomes among patients with venous thromboembolism with and without chronic kidney disease
Importance Patients with venous thromboembolism (VTE) and concomitant chronic kidney
disease (CKD) have been reported to have a higher risk of thrombosis and major bleeding …
disease (CKD) have been reported to have a higher risk of thrombosis and major bleeding …
[HTML][HTML] Severe renal impairment and risk of bleeding during anticoagulation for venous thromboembolism
J Catella, L Bertoletti, P Mismetti, E Ollier… - Journal of Thrombosis …, 2020 - Elsevier
Background Detection of severe renal impairment in patients with venous thromboembolism
(VTE) is mandatory both for selecting anticoagulant therapy and for evaluating major …
(VTE) is mandatory both for selecting anticoagulant therapy and for evaluating major …
Venous thromboembolism in chronic kidney disease: epidemiology, the role of proteinuria, CKD severity and therapeutics
The worldwide prevalence of chronic kidney disease is 10–15% of the adult population, is
rising and increases susceptibility to venous thromboembolism (VTE). In this narrative …
rising and increases susceptibility to venous thromboembolism (VTE). In this narrative …
[HTML][HTML] Effectiveness and safety of apixaban versus warfarin in venous thromboembolism patients with chronic kidney disease
There has been limited evidence reported about the outcomes of oral anticoagulants among
patients with venous thromboembolism (VTE) and chronic kidney disease (CKD), especially …
patients with venous thromboembolism (VTE) and chronic kidney disease (CKD), especially …
Clinical outcome of patients with venous thromboembolism and renal insufficiency
C Falgá, JA Capdevila, S Soler… - Thrombosis and …, 2007 - thieme-connect.com
There is little information on the clinical outcome of patients with venous thromboembolism
and renal insufficiency. RIETE is an ongoing, prospective registry of consecutive patients …
and renal insufficiency. RIETE is an ongoing, prospective registry of consecutive patients …
[HTML][HTML] 36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE
Background Venous thromboembolism (VTE), encompassing both deep vein thrombosis
(DVT) and pulmonary embolism (PE), is a leading cause of morbidity and mortality …
(DVT) and pulmonary embolism (PE), is a leading cause of morbidity and mortality …
[HTML][HTML] Mechanisms and mitigating factors for venous thromboembolism in chronic kidney disease: the REGARDS study
Essentials• Chronic kidney disease (CKD) is associated with procoagulant and inflammatory
biomarkers.• We studied the association of CKD and venous thromboembolism (VTE) in a …
biomarkers.• We studied the association of CKD and venous thromboembolism (VTE) in a …
Venous thromboembolism in patients with renal insufficiency: findings from the RIETE Registry
BACKGROUND: Current guidelines make no specific recommendations for venous
thromboembolism (VTE) treatment in patients with renal insufficiency, but some experts …
thromboembolism (VTE) treatment in patients with renal insufficiency, but some experts …
Association of mild to moderate chronic kidney disease with venous thromboembolism: pooled analysis of five prospective general population cohorts
Background—Recent findings suggest that chronic kidney disease (CKD) may be
associated with an increased risk of venous thromboembolism (VTE). Given the high …
associated with an increased risk of venous thromboembolism (VTE). Given the high …
Pulmonary embolism in chronic kidney disease and end-stage renal disease hospitalizations: trends, outcomes, and predictors of mortality in the United States
Background: It is well-known that patients with chronic kidney disease and end-stage renal
disease are at increased risk of pulmonary embolism than patients with normal kidney …
disease are at increased risk of pulmonary embolism than patients with normal kidney …
相关搜索
- kidney disease venous thromboembolism
- renal insufficiency venous thromboembolism
- assessment of outcomes venous thromboembolism
- kidney disease assessment of outcomes
- kidney disease pulmonary embolism
- ckd severity venous thromboembolism
- garfield vte venous thromboembolism
- 36 month venous thromboembolism
- kidney disease ckd severity
- population cohorts venous thromboembolism
- riete registry venous thromboembolism
- kidney disease population cohorts
- kidney disease predictors of mortality
- kidney disease end stage
- safety of apixaban thromboembolism patients
- mitigating factors venous thromboembolism